What is Upstream Bio, Inc. Common Stock's Market Cap?

Upstream Bio, Inc. Common Stock's Market Cap is $334.1M, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's Enterprise Value?

Upstream Bio, Inc. Common Stock's Enterprise Value is $73.0M, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's Price / Sales?

Upstream Bio, Inc. Common Stock's Price / Sales is 105.8×, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's EV / Revenue?

Upstream Bio, Inc. Common Stock's EV / Revenue is 23.1×, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's EV / EBITDA?

Upstream Bio, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's Revenue (TTM)?

Upstream Bio, Inc. Common Stock's Revenue (TTM) is $3.2M, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's Net Income (TTM)?

Upstream Bio, Inc. Common Stock's Net Income (TTM) is -$156.5M, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's EBITDA?

Upstream Bio, Inc. Common Stock's EBITDA is -$169.8M, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's Diluted EPS (TTM)?

Upstream Bio, Inc. Common Stock's Diluted EPS (TTM) is -2.86, based on as-reported figures from SEC (XBRL) filings.

What is Upstream Bio, Inc. Common Stock's EBITDA Margin?

Upstream Bio, Inc. Common Stock's EBITDA Margin is -5376.3%, based on as-reported figures from SEC (XBRL) filings.

Upstream Bio, Inc. Common Stock (UPB) Financial Statements

Upstream Bio, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG017Y2X950

XNAS · usd

6.10▼ 0.09 (-1.45%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close6.19

Day's Range5.77 – 6.21

52-Week Range5.77 – 33.69

Volume948.8K

Avg Volume632.1K

Share Statistics

Shares Outstanding

Employees75

ExchangeXNAS

Listed2024-10-11

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Upstream Bio, Inc. Common Stock (UPB)

What is Upstream Bio, Inc. Common Stock's Market Cap?: Upstream Bio, Inc. Common Stock's Market Cap is $334.1M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Enterprise Value?: Upstream Bio, Inc. Common Stock's Enterprise Value is $73.0M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Price / Sales?: Upstream Bio, Inc. Common Stock's Price / Sales is 105.8×, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's EV / Revenue?: Upstream Bio, Inc. Common Stock's EV / Revenue is 23.1×, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's EV / EBITDA?: Upstream Bio, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Revenue (TTM)?: Upstream Bio, Inc. Common Stock's Revenue (TTM) is $3.2M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Net Income (TTM)?: Upstream Bio, Inc. Common Stock's Net Income (TTM) is -$156.5M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's EBITDA?: Upstream Bio, Inc. Common Stock's EBITDA is -$169.8M, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's Diluted EPS (TTM)?: Upstream Bio, Inc. Common Stock's Diluted EPS (TTM) is -2.86, based on as-reported figures from SEC (XBRL) filings.
What is Upstream Bio, Inc. Common Stock's EBITDA Margin?: Upstream Bio, Inc. Common Stock's EBITDA Margin is -5376.3%, based on as-reported figures from SEC (XBRL) filings.